S.B.M. Srl

SBM (Science et BioMatériaux) is a specialized medical technology company that develops and manufactures advanced biomaterials for bone surgery and regenerative medicine. Founded in 1991, the company operates with a significant presence in France and Italy, where its subsidiary S.B.M. S.r.l. is central to the research and production of bioabsorbable implants. SBM's core expertise lies in bioceramics and bioabsorbable polymers, which are utilized to create products that facilitate natural bone regeneration and provide stable internal fixation without the need for permanent metal implants. Its flagship product lines, including Biosorb and Phusis, are widely used in trauma, spine, and sports medicine procedures globally. In July 2024, SBM was acquired by Enovis Corporation, further strengthening its position within the global orthopedic market.